Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Clinical trial NCT07730177 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07730177
Sponsor: Sanaria Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malaria (Plasmodium Falciparum)

Start date: 2027-03-01
Primary completion: 2027-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.